OncoMed Pharmaceuticals (OMED) PT Raised to $16 at Jefferies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/10/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. UNH
7. SPY
8. CVS
9. SBUX
10. AXP

Go back to OncoMed Pharmaceuticals (OMED) PT Raised to $16 at Jefferies

OncoMed Pharmaceuticals Reports Second Quarter 2016 Financial Results

August 9, 2016 4:07 PM EDT

 OncoMed Management to Host Conference Call/Webcast this Afternoon at 4:30 p.m. ET/1:30 p.m. PT

REDWOOD CITY, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq: OMED), a clinical-stage company developing novel anti-cancer stem cell and immuno-oncology therapeutics, today reported second quarter financial results.  As of June 30, 2016, cash, cash equivalents and short-term investments totaled $171.5 million. 

With seven OncoMed-discovered drugs in fourteen clinical trials, we enter the second half of this year following the presentation of encouraging data from across our pipeline at the AACR and ASCO annual meetings,... More